G1 Therapeutics Inc (GTHX) Company Profile & Statistics

G1 Therapeutics Inc
GTHX
(Nasdaq - US)
N/A
4.73
+0.11 (+2.38%)
in:usd•As of: May 14, 2024 14:32 UTC -4
Open
4.83
High
4.83
Low
4.65

About G1 Therapeutics Inc

CEO

John E. Bailey, Jr.

Headquarters

700 park offices drive, suite 200

research triangle park, nc 27709, united states

Auditor

PricewaterhouseCoopers LLP

Employees

100

Share Holders

Website

www.g1therapeutics.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing novel, small-molecule therapies which address significant unmet needs in the treatment of cancer. The company's product pipeline consists of CDK4/6, Trilaciclib (G1T28), G1T38 and G1T48. G1 Therapeutics, Inc. is based in Research Triangle Park, NC.

G1 Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	247.28M
Enterprise Value	266.56M
Enterprise Value/EBITDA (ttm)	-7.10
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	8.99
Price to Sales (ttm)	2.97
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	87.99%
Operating Margin (ttm)	-36.40%
Profit Margin (ttm)	-103.44%
Return on Equity (ttm)	-74.75%
Return on Invested Capital (ttm)	-46.33%
Return on Assets (ttm)	-24.25%

Income Statement

Revenue (ttm)	82.51M
Revenue Per Share (ttm)	1.58
Gross Profit (ttm)	75.32M
EBITDA (ttm)³	-37.54M
Net Income Avi to Common (ttm)	-47.97M
Diluted EPS (ttm)	-0.62

Share Statistics

Beta (5Y Monthly)	1.71
52-Week Change	61.99%
S&P500 52-Week Change	26.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	52.20M
Dividend Yield	0.00%
Float ⁴	47.98M
% Held by Insiders	8.23%
% Held by Institutions	24.21%

Balance Sheet

Total Cash (mrq)	82.22M
Total Cash Per Share (mrq)	1.58
Total Debt (mrq)	51.56M
Total Debt/Equity (mrq)	145.70%
Current Ratio (mrq)	3.87%
Quick Ratio (mrq)	2.55%
Book Value Per Share (mrq)	0.68

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.74
Free Cash Flow (ytd)	-38.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

G1 Therapeutics Inc

Trade With A Regulated Broker